Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
Goldman Sachs International T/M Eq Inv GITRX
- NAV / 1-Day Return 12.56 / +1.21 %
- Total Assets 859.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.970%
- Distribution Fee Level Average
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment —
- Status Open
- TTM Yield 2.08%
- Turnover 132%
USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 12:21 AM GMT+0
Morningstar’s Analysis GITRX
Will GITRX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 2.69 | 21.1 Mil | Healthcare |
Nestle SA | 2.45 | 19.2 Mil | Consumer Defensive |
ASML Holding NV | 2.44 | 19.1 Mil | Technology |
Novartis AG Registered Shares | 2.00 | 15.7 Mil | Healthcare |
SAP SE | 1.64 | 12.9 Mil | Technology |
Airbus SE | 1.40 | 11.0 Mil | Industrials |
Siemens AG | 1.38 | 10.8 Mil | Industrials |
UBS Group AG | 1.32 | 10.3 Mil | Financial Services |
Air Liquide SA | 1.27 | 9.9 Mil | Basic Materials |
AIA Group Ltd | 1.25 | 9.8 Mil | Financial Services |